全文获取类型
收费全文 | 1024篇 |
免费 | 86篇 |
国内免费 | 16篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 62篇 |
妇产科学 | 15篇 |
基础医学 | 150篇 |
口腔科学 | 18篇 |
临床医学 | 116篇 |
内科学 | 252篇 |
皮肤病学 | 13篇 |
神经病学 | 53篇 |
特种医学 | 142篇 |
外科学 | 127篇 |
综合类 | 11篇 |
预防医学 | 51篇 |
眼科学 | 12篇 |
药学 | 77篇 |
肿瘤学 | 26篇 |
出版年
2022年 | 10篇 |
2021年 | 14篇 |
2020年 | 8篇 |
2019年 | 13篇 |
2018年 | 12篇 |
2016年 | 8篇 |
2015年 | 14篇 |
2014年 | 19篇 |
2013年 | 28篇 |
2012年 | 22篇 |
2011年 | 35篇 |
2010年 | 27篇 |
2009年 | 36篇 |
2008年 | 27篇 |
2007年 | 42篇 |
2006年 | 31篇 |
2005年 | 32篇 |
2004年 | 29篇 |
2003年 | 26篇 |
2002年 | 31篇 |
2001年 | 27篇 |
2000年 | 33篇 |
1999年 | 43篇 |
1998年 | 33篇 |
1997年 | 37篇 |
1996年 | 35篇 |
1995年 | 19篇 |
1994年 | 20篇 |
1993年 | 21篇 |
1992年 | 15篇 |
1991年 | 16篇 |
1990年 | 23篇 |
1989年 | 22篇 |
1988年 | 26篇 |
1987年 | 28篇 |
1986年 | 22篇 |
1985年 | 32篇 |
1984年 | 11篇 |
1983年 | 26篇 |
1982年 | 20篇 |
1981年 | 18篇 |
1980年 | 14篇 |
1979年 | 12篇 |
1978年 | 12篇 |
1977年 | 18篇 |
1976年 | 8篇 |
1975年 | 5篇 |
1974年 | 10篇 |
1969年 | 6篇 |
1965年 | 4篇 |
排序方式: 共有1126条查询结果,搜索用时 15 毫秒
51.
Louise L. Dunn Philippa J.L. Simpson Hamish C. Prosser Laura Lecce Gloria S.C. Yuen Andrew Buckle Daniel P. Sieveking Laura Z. Vanags Patrick R. Lim Renee W.Y. Chow Yuen Ting Lam Zoe Clayton Shisan Bao Michael J. Davies Nadina Stadler David S. Celermajer Roland Stocker Christina A. Bursill John P. Cooke Martin K.C. Ng 《Diabetes》2014,63(2):675-687
Impaired angiogenesis in ischemic tissue is a hallmark of diabetes. Thioredoxin-interacting protein (TXNIP) is an exquisitely glucose-sensitive gene that is overexpressed in diabetes. As TXNIP modulates the activity of the key angiogenic cytokine vascular endothelial growth factor (VEGF), we hypothesized that hyperglycemia-induced dysregulation of TXNIP may play a role in the pathogenesis of impaired angiogenesis in diabetes. In the current study, we report that high glucose–mediated overexpression of TXNIP induces a widespread impairment in endothelial cell (EC) function and survival by reducing VEGF production and sensitivity to VEGF action, findings that are rescued by silencing TXNIP with small interfering RNA. High glucose–induced EC dysfunction was recapitulated in normal glucose conditions by overexpressing either TXNIP or a TXNIP C247S mutant unable to bind thioredoxin, suggesting that TXNIP effects are largely independent of thioredoxin activity. In streptozotocin-induced diabetic mice, TXNIP knockdown to nondiabetic levels rescued diabetes-related impairment of angiogenesis, arteriogenesis, blood flow, and functional recovery in an ischemic hindlimb. These findings were associated with in vivo restoration of VEGF production to nondiabetic levels. These data implicate a critical role for TXNIP in diabetes-related impairment of ischemia-mediated angiogenesis and identify TXNIP as a potential therapeutic target for the vascular complications of diabetes. 相似文献
52.
53.
54.
运动性心律失常是指发生于机体剧烈运动期间或之后的心律失常。临床表现不一,从心悸、头晕、晕厥、心绞痛、急性心肌梗死和充血性心力衰竭,甚至到心脏性猝死。运动性心律失常可见于心肌缺血,如患有动脉粥样硬化性心脏病以及患有原发性或继发性心肌病的患者。然而,也可能发生在似乎健康的个体。在后一组人群中,运动性心律失常可以是良性的,但也可以是获得性(如药物诱发)或先天性(如先天性长QT综合征或致心律失常性右室发育不良)心电活动或结构的异常而呈恶性。这种潜在病理生理学机制的复杂性,使运动性心律失常的诊断和治疗成为临床医学上的… 相似文献
55.
We sought to determine whether Litomosoides sigmodontis, a filarial infection of rodents, protects against type 1 diabetes in non‐obese diabetic (NOD) mice. Six‐week‐old NOD mice were sham‐infected or infected with either L3 larvae, adult male worms, or adult female worms. Whereas 82% of uninfected NOD mice developed diabetes by 25 weeks of age, no L. sigmodontis‐infected mice developed disease. Although all mice had evidence of ongoing islet cell inflammation by histology, L. sigmodontis‐infected mice had greater numbers of total islets and non‐infiltrated islets than control mice. Protection against diabetes was associated with a T helper type 2 (Th2) shift, as interleukin‐4 (IL‐4) and IL‐5 release from α‐CD3/α‐CD28‐stimulated splenocytes was greater in L. sigmodontis‐infected mice than in uninfected mice. Increased circulating levels of insulin‐specific immunoglobulin G1, showed that this Th2 shift occurs in response to one of the main autoantigens in diabetes. Multicolour flow cytometry studies demonstrated that protection against diabetes in L. sigmodontis‐infected NOD mice was associated with significantly increased numbers of splenic CD4+ CD25+ FoxP3+ regulatory T cells. Interestingly, injection of crude worm antigen into NOD mice also resulted in protection against type 1 diabetes, though to a lesser degree than infection with live L. sigmodontis worms. In conclusion, these studies demonstrate that filarial worms can protect against the onset of type 1 diabetes in NOD mice. This protection is associated with a Th2 shift, as demonstrated by cytokine and antibody production, and with an increase in CD4+ CD25+ FoxP3+ regulatory T cells. 相似文献
56.
Chicken growth-associated protein (GAP)-43: primary structure and regulated expression of mRNA during embryogenesis 总被引:4,自引:0,他引:4
Growth-associated protein (GAP)-43 is a neuron-specific phosphoprotein whose expression is associated with axonal outgrowth during neuronal development and regeneration. In order to investigate the expression of this gene product in the early developing nervous system we have isolated and sequenced a cDNA for chicken GAP-43. The predicted amino acid sequence for chicken GAP-43 displays extensive similarity to that of the mammalian protein, particularly in the amino-terminal region, to which functional domains of the protein have been assigned. The cDNA hybridizes with two RNAs of differing molecular weights on Northern blots; both appear to be regulated similarly. These RNAs first appear in the brain on embryonic day 3 (E3), suggesting that GAP-43 begins to be expressed when neuroblasts become post-mitotic. In situ hybridization analysis reveals that GAP-43 RNA is expressed by several neural structures in the chick embryo, including derivatives of the neural tube, neural crest, and neuroectodermal placodes. 相似文献
57.
Recombinant human granulocyte colony-stimulating factor (G-CSF) treatment has been shown to increase average neutrophil counts substantially in patients with childhood-onset cyclic neutropenia (or "cyclic hematopoiesis"), but not to eliminate the cyclic oscillations of neutrophil counts or those of other blood elements (monocytes, platelets, eosinophils, and reticulocytes) that are characteristic of this hematopoietic disorder. Indeed, oscillations of neutrophil counts are amplified during G-CSF treatment. We have compared the effects of recombinant granulocyte-macrophage-CSF (GM-CSF) with those of G-CSF in three patients with this disease (2 men and 1 woman, 17, 30, and 32 years of age). These patients were treated with GM-CSF (2.1 micrograms/kg/day, subcutaneously) for 6 weeks, preceded and followed by 6 to 13 weeks of detailed observation to document changes in the cyclic oscillations of blood neutrophils and other blood elements; two of the patients were subsequently treated with G-CSF (5.0 micrograms/kg/d, subcutaneously) and observed for comparable periods of time. Unlike G-CSF treatment, which increased average neutrophil counts more than 20-fold, GM-CSF increased neutrophil counts only modestly, from 1.6- to 3.9-fold, although eosinophilia of varying prominence was induced in each patient. However, at the same time, GM-CSF treatment dampened or eliminated the multilineage oscillations of circulating blood elements (neutrophils, monocytes, platelets, and/or reticulocytes) in each of the patients. In contrast, G-CSF treatment of the same patients markedly amplified the oscillations of neutrophil counts and caused the cycling of other blood elements (monocytes in particular) to become more distinct. These findings support the conclusion that the distinctive cycling of blood cell production in childhood-onset cyclic neutropenia results from abnormalities in the coordinate regulation of both GM-CSF-responsive, multipotential progenitor cells and G-CSF-responsive, lineage-restricted, neutrophil progenitors. 相似文献
58.
Christian E Oberkofler Philipp Dutkowski Reto Stocker Reto A Schuepbach John F Stover Pierre-Alain Clavien Markus Béchir 《Critical care (London, England)》2010,14(3):R117
Introduction
The impact of model of end stage liver disease (MELD) score on postoperative morbidity and mortality is still elusive, especially for high MELD. There are reports of poorer patient outcome in transplant candidates with high MELD score, others though report no influence of MELD score on outcome and survival. 相似文献59.
Kyle L. Hoehn Adam B. Salmon Cordula Hohnen-Behrens Nigel Turner Andrew J. Hoy Ghassan J. Maghzal Roland Stocker Holly Van Remmen Edward W. Kraegen Greg J. Cooney Arlan R. Richardson David E. James 《Proceedings of the National Academy of Sciences of the United States of America》2009,106(42):17787-17792
We know a great deal about the cellular response to starvation via AMPK, but less is known about the reaction to nutrient excess. Insulin resistance may be an appropriate response to nutrient excess, but the cellular sensors that link these parameters remain poorly defined. In the present study we provide evidence that mitochondrial superoxide production is a common feature of many different models of insulin resistance in adipocytes, myotubes, and mice. In particular, insulin resistance was rapidly reversible upon exposure to agents that act as mitochondrial uncouplers, ETC inhibitors, or mitochondrial superoxide dismutase (MnSOD) mimetics. Similar effects were observed with overexpression of mitochondrial MnSOD. Furthermore, acute induction of mitochondrial superoxide production using the complex III antagonist antimycin A caused rapid attenuation of insulin action independently of changes in the canonical PI3K/Akt pathway. These results were validated in vivo in that MnSOD transgenic mice were partially protected against HFD induced insulin resistance and MnSOD+/− mice were glucose intolerant on a standard chow diet. These data place mitochondrial superoxide at the nexus between intracellular metabolism and the control of insulin action potentially defining this as a metabolic sensor of energy excess. 相似文献
60.
Mark Onslow Sally Stocker Ann Packman Sharynne McLeod 《Clinical linguistics & phonetics》2013,27(1):21-33
It is known that operant treatments can control stuttering in children. However, at present it is unknown why such treatments are effective. Changes in the usual way of speaking are frequently observed after behavioural treatments for adults who stutter, and it is possible that operant treatments for children also invoke such changes. To explore this idea, selected acoustic measures of speech timing were made in eight preschool children before and after receiving the Lidcombe Program, which is an operant treatment for stuttering. No systematic changes were detected after treatment. Considering this finding and a previous report, there is no evidence to suggest that the reductions in stuttering that occur with this treatment are related to systematic changes in speech timing or curtailment of language function. 相似文献